{"transactions":[{"id":4639658,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-13T21:20:05.000Z","date":"2026-10-09","kind":"exercise","planned":true,"acquired":false,"shares":192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024."}],"balance_after":2267,"derivative":{"exercise_price":39.42,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":192},"source":{"system":"sec-edgar","filing":"0001578852-26-000026","document":"form4-10132026_051001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1578852/000157885226000026/form4-10132026_051001.xml","form_type":"4"}},{"id":4639657,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-10-13T21:20:05.000Z","date":"2026-10-09","kind":"sale","planned":true,"acquired":false,"shares":192,"price":64.26,"value":12337.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $64.00 to $64.70 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":105272,"source":{"system":"sec-edgar","filing":"0001578852-26-000026","document":"form4-10132026_051001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1578852/000157885226000026/form4-10132026_051001.xml","form_type":"4"}},{"id":4639656,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-10-13T21:20:05.000Z","date":"2026-10-09","kind":"exercise","planned":true,"acquired":true,"shares":192,"price":39.42,"value":7568.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."}],"balance_after":105464,"source":{"system":"sec-edgar","filing":"0001578852-26-000026","document":"form4-10132026_051001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1578852/000157885226000026/form4-10132026_051001.xml","form_type":"4"}},{"id":4637293,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-07T21:20:05.000Z","date":"2026-10-06","kind":"exercise","planned":true,"acquired":false,"shares":435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024."}],"balance_after":2459,"derivative":{"exercise_price":39.42,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":435},"source":{"system":"sec-edgar","filing":"0001578852-26-000024","document":"form4-10072026_051001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1578852/000157885226000024/form4-10072026_051001.xml","form_type":"4"}},{"id":4637292,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-07T21:20:05.000Z","date":"2026-10-05","kind":"exercise","planned":true,"acquired":false,"shares":1638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024."}],"balance_after":2894,"derivative":{"exercise_price":39.42,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":1638},"source":{"system":"sec-edgar","filing":"0001578852-26-000024","document":"form4-10072026_051001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1578852/000157885226000024/form4-10072026_051001.xml","form_type":"4"}},{"id":4637291,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-10-07T21:20:05.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":435,"price":64.16,"value":27909.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $64.00 to $64.90 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":105272,"source":{"system":"sec-edgar","filing":"0001578852-26-000024","document":"form4-10072026_051001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1578852/000157885226000024/form4-10072026_051001.xml","form_type":"4"}},{"id":4637290,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-10-07T21:20:05.000Z","date":"2026-10-06","kind":"exercise","planned":true,"acquired":true,"shares":435,"price":39.42,"value":17147.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."}],"balance_after":105707,"source":{"system":"sec-edgar","filing":"0001578852-26-000024","document":"form4-10072026_051001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1578852/000157885226000024/form4-10072026_051001.xml","form_type":"4"}},{"id":4637289,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-10-07T21:20:05.000Z","date":"2026-10-05","kind":"sale","planned":true,"acquired":false,"shares":1638,"price":64.03,"value":104881.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $64.00 to $64.34 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":105272,"source":{"system":"sec-edgar","filing":"0001578852-26-000024","document":"form4-10072026_051001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1578852/000157885226000024/form4-10072026_051001.xml","form_type":"4"}},{"id":4637288,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-10-07T21:20:05.000Z","date":"2026-10-05","kind":"exercise","planned":true,"acquired":true,"shares":1638,"price":39.42,"value":64569.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."}],"balance_after":106910,"source":{"system":"sec-edgar","filing":"0001578852-26-000024","document":"form4-10072026_051001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1578852/000157885226000024/form4-10072026_051001.xml","form_type":"4"}},{"id":681956,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-19T21:20:05.000Z","date":"2026-08-17","kind":"exercise","planned":true,"acquired":false,"shares":2813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025."}],"balance_after":16876,"derivative":{"exercise_price":25.69,"expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":2813},"source":{"system":"sec-edgar","filing":"0001578852-26-000022","document":"form4-08192026_050801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000022/form4-08192026_050801.xml","form_type":"4"}},{"id":681955,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-08-19T21:20:05.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":969,"price":72.9,"value":70640.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $72.73 to $73.02 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":105272,"source":{"system":"sec-edgar","filing":"0001578852-26-000022","document":"form4-08192026_050801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000022/form4-08192026_050801.xml","form_type":"4"}},{"id":681954,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-08-19T21:20:05.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":1844,"price":72.39,"value":133487.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $71.72 to $72.67 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":106241,"source":{"system":"sec-edgar","filing":"0001578852-26-000022","document":"form4-08192026_050801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000022/form4-08192026_050801.xml","form_type":"4"}},{"id":681953,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-08-19T21:20:05.000Z","date":"2026-08-17","kind":"exercise","planned":true,"acquired":true,"shares":2813,"price":25.69,"value":72265.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."}],"balance_after":108085,"source":{"system":"sec-edgar","filing":"0001578852-26-000022","document":"form4-08192026_050801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000022/form4-08192026_050801.xml","form_type":"4"}},{"id":713047,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-08T21:20:08.000Z","date":"2026-07-06","kind":"exercise","planned":true,"acquired":false,"shares":2813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026."}],"balance_after":28125,"derivative":{"exercise_price":46.54,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":2813},"source":{"system":"sec-edgar","filing":"0001578852-26-000020","document":"form4-07082026_050704.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000020/form4-07082026_050704.xml","form_type":"4"}},{"id":713046,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-08T21:20:08.000Z","date":"2026-07-06","kind":"exercise","planned":true,"acquired":false,"shares":2226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted on January 5, 2023 and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024."}],"balance_after":4532,"derivative":{"exercise_price":39.42,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":2266},"source":{"system":"sec-edgar","filing":"0001578852-26-000020","document":"form4-07082026_050704.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000020/form4-07082026_050704.xml","form_type":"4"}},{"id":713045,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-07-08T21:20:08.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":745,"price":86.38,"value":64353.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $86.18 to $86.73 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":105272,"source":{"system":"sec-edgar","filing":"0001578852-26-000020","document":"form4-07082026_050704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000020/form4-07082026_050704.xml","form_type":"4"}},{"id":713044,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-07-08T21:20:08.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":645,"price":85.84,"value":55366.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.18 to $86.17 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":106017,"source":{"system":"sec-edgar","filing":"0001578852-26-000020","document":"form4-07082026_050704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000020/form4-07082026_050704.xml","form_type":"4"}},{"id":713043,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-07-08T21:20:08.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":1036,"price":84.41,"value":87448.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $83.98 to $84.94 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":106662,"source":{"system":"sec-edgar","filing":"0001578852-26-000020","document":"form4-07082026_050704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000020/form4-07082026_050704.xml","form_type":"4"}},{"id":713042,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-07-08T21:20:08.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":387,"price":83.1,"value":32159.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $82.76 to $83.68 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":107698,"source":{"system":"sec-edgar","filing":"0001578852-26-000020","document":"form4-07082026_050704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000020/form4-07082026_050704.xml","form_type":"4"}},{"id":713041,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-07-08T21:20:08.000Z","date":"2026-07-06","kind":"exercise","planned":true,"acquired":true,"shares":2813,"price":46.54,"value":130917.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."}],"balance_after":108085,"source":{"system":"sec-edgar","filing":"0001578852-26-000020","document":"form4-07082026_050704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000020/form4-07082026_050704.xml","form_type":"4"}},{"id":713040,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-07-08T21:20:08.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":601,"price":86.38,"value":51914.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $86.18 to $86.73 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":105272,"source":{"system":"sec-edgar","filing":"0001578852-26-000020","document":"form4-07082026_050704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000020/form4-07082026_050704.xml","form_type":"4"}},{"id":713039,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-07-08T21:20:08.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":519,"price":85.84,"value":44550.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.18 to $86.17 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":105873,"source":{"system":"sec-edgar","filing":"0001578852-26-000020","document":"form4-07082026_050704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000020/form4-07082026_050704.xml","form_type":"4"}},{"id":713038,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-07-08T21:20:08.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":833,"price":84.41,"value":70313.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $83.98 to $84.94 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":106392,"source":{"system":"sec-edgar","filing":"0001578852-26-000020","document":"form4-07082026_050704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000020/form4-07082026_050704.xml","form_type":"4"}},{"id":713037,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-07-08T21:20:08.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":313,"price":83.1,"value":26010.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $82.76 to $83.68 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":107225,"source":{"system":"sec-edgar","filing":"0001578852-26-000020","document":"form4-07082026_050704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000020/form4-07082026_050704.xml","form_type":"4"}},{"id":713036,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-07-08T21:20:08.000Z","date":"2026-07-06","kind":"exercise","planned":true,"acquired":true,"shares":2266,"price":39.42,"value":89325.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."}],"balance_after":107538,"source":{"system":"sec-edgar","filing":"0001578852-26-000020","document":"form4-07082026_050704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000020/form4-07082026_050704.xml","form_type":"4"}},{"id":730974,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-22T21:20:05.000Z","date":"2026-06-17","kind":"exercise","planned":true,"acquired":false,"shares":2012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026."}],"balance_after":30938,"derivative":{"exercise_price":46.54,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":2012},"source":{"system":"sec-edgar","filing":"0001578852-26-000018","document":"form4-06222026_050601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000018/form4-06222026_050601.xml","form_type":"4"}},{"id":730973,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-22T21:20:05.000Z","date":"2026-06-17","kind":"exercise","planned":true,"acquired":false,"shares":8510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026."}],"balance_after":32950,"derivative":{"exercise_price":46.54,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":8510},"source":{"system":"sec-edgar","filing":"0001578852-26-000018","document":"form4-06222026_050601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000018/form4-06222026_050601.xml","form_type":"4"}},{"id":730972,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-06-22T21:20:05.000Z","date":"2026-06-17","kind":"sale","planned":true,"acquired":false,"shares":309,"price":79.25,"value":24488.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $79.00 to $79.48 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":105272,"source":{"system":"sec-edgar","filing":"0001578852-26-000018","document":"form4-06222026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000018/form4-06222026_050601.xml","form_type":"4"}},{"id":730971,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-06-22T21:20:05.000Z","date":"2026-06-17","kind":"sale","planned":true,"acquired":false,"shares":1703,"price":78.5,"value":133685.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $78.00 to $78.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":105581,"source":{"system":"sec-edgar","filing":"0001578852-26-000018","document":"form4-06222026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000018/form4-06222026_050601.xml","form_type":"4"}},{"id":730970,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-06-22T21:20:05.000Z","date":"2026-06-17","kind":"exercise","planned":true,"acquired":true,"shares":2012,"price":46.54,"value":93638.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."}],"balance_after":107284,"source":{"system":"sec-edgar","filing":"0001578852-26-000018","document":"form4-06222026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000018/form4-06222026_050601.xml","form_type":"4"}},{"id":730969,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-06-22T21:20:05.000Z","date":"2026-06-17","kind":"sale","planned":true,"acquired":false,"shares":1850,"price":79.24,"value":146594.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $79.00 to $79.49 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":105272,"source":{"system":"sec-edgar","filing":"0001578852-26-000018","document":"form4-06222026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000018/form4-06222026_050601.xml","form_type":"4"}},{"id":730968,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-06-22T21:20:05.000Z","date":"2026-06-17","kind":"sale","planned":true,"acquired":false,"shares":6600,"price":78.5,"value":518100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $78.00 to $78.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":107122,"source":{"system":"sec-edgar","filing":"0001578852-26-000018","document":"form4-06222026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000018/form4-06222026_050601.xml","form_type":"4"}},{"id":730967,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-06-22T21:20:05.000Z","date":"2026-06-17","kind":"exercise","planned":true,"acquired":true,"shares":8510,"price":46.54,"value":396055.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."}],"balance_after":113722,"source":{"system":"sec-edgar","filing":"0001578852-26-000018","document":"form4-06222026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000018/form4-06222026_050601.xml","form_type":"4"}},{"id":773030,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-19T21:20:05.000Z","date":"2026-05-15","kind":"exercise","planned":true,"acquired":false,"shares":2812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025."}],"balance_after":19689,"derivative":{"exercise_price":25.69,"expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":2812},"source":{"system":"sec-edgar","filing":"0001578852-26-000016","document":"form4-05192026_050501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000016/form4-05192026_050501.xml","form_type":"4"}},{"id":773029,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-05-19T21:20:05.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":456,"price":72.67,"value":33137.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $72.41 to $72.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":105212,"source":{"system":"sec-edgar","filing":"0001578852-26-000016","document":"form4-05192026_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000016/form4-05192026_050501.xml","form_type":"4"}},{"id":773028,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-05-19T21:20:05.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":2356,"price":72.08,"value":169820.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $71.41 to $72.29 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":105668,"source":{"system":"sec-edgar","filing":"0001578852-26-000016","document":"form4-05192026_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000016/form4-05192026_050501.xml","form_type":"4"}},{"id":773027,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-05-19T21:20:05.000Z","date":"2026-05-15","kind":"exercise","planned":true,"acquired":true,"shares":2812,"price":25.69,"value":72240.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."}],"balance_after":108024,"source":{"system":"sec-edgar","filing":"0001578852-26-000016","document":"form4-05192026_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000016/form4-05192026_050501.xml","form_type":"4"}},{"id":783104,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-12T21:20:06.000Z","date":"2026-05-08","kind":"exercise","planned":true,"acquired":false,"shares":800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026."}],"balance_after":41460,"derivative":{"exercise_price":46.54,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":800},"source":{"system":"sec-edgar","filing":"0001578852-26-000014","document":"form4-05122026_050501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000014/form4-05122026_050501.xml","form_type":"4"}},{"id":783103,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-12T21:20:06.000Z","date":"2026-05-08","kind":"exercise","planned":true,"acquired":false,"shares":2740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026."}],"balance_after":42260,"derivative":{"exercise_price":46.54,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":2740},"source":{"system":"sec-edgar","filing":"0001578852-26-000014","document":"form4-05122026_050501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000014/form4-05122026_050501.xml","form_type":"4"}},{"id":783102,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-05-12T21:20:06.000Z","date":"2026-05-08","kind":"sale","planned":true,"acquired":false,"shares":600,"price":79.28,"value":47568.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $79.02 to $79.52 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":105212,"source":{"system":"sec-edgar","filing":"0001578852-26-000014","document":"form4-05122026_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000014/form4-05122026_050501.xml","form_type":"4"}},{"id":783101,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-05-12T21:20:06.000Z","date":"2026-05-08","kind":"sale","planned":true,"acquired":false,"shares":200,"price":78,"value":15600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."}],"balance_after":105812,"source":{"system":"sec-edgar","filing":"0001578852-26-000014","document":"form4-05122026_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000014/form4-05122026_050501.xml","form_type":"4"}},{"id":783100,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-05-12T21:20:06.000Z","date":"2026-05-08","kind":"exercise","planned":true,"acquired":true,"shares":800,"price":46.54,"value":37232.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."}],"balance_after":106012,"source":{"system":"sec-edgar","filing":"0001578852-26-000014","document":"form4-05122026_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000014/form4-05122026_050501.xml","form_type":"4"}},{"id":783099,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-05-12T21:20:06.000Z","date":"2026-05-08","kind":"sale","planned":true,"acquired":false,"shares":1900,"price":79.31,"value":150689.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $79.03 to $79.70 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":105212,"source":{"system":"sec-edgar","filing":"0001578852-26-000014","document":"form4-05122026_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000014/form4-05122026_050501.xml","form_type":"4"}},{"id":783098,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-05-12T21:20:06.000Z","date":"2026-05-08","kind":"sale","planned":true,"acquired":false,"shares":840,"price":78.23,"value":65713.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $78.00 to $78.72 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":107112,"source":{"system":"sec-edgar","filing":"0001578852-26-000014","document":"form4-05122026_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000014/form4-05122026_050501.xml","form_type":"4"}},{"id":783097,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-05-12T21:20:06.000Z","date":"2026-05-08","kind":"exercise","planned":true,"acquired":true,"shares":2740,"price":46.54,"value":127519.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."}],"balance_after":107952,"source":{"system":"sec-edgar","filing":"0001578852-26-000014","document":"form4-05122026_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000014/form4-05122026_050501.xml","form_type":"4"}},{"id":812848,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-08T21:20:05.000Z","date":"2026-04-06","kind":"exercise","planned":true,"acquired":false,"shares":2265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on January 5, 2023 and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024."}],"balance_after":6798,"derivative":{"exercise_price":39.42,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":2265},"source":{"system":"sec-edgar","filing":"0001578852-26-000012","document":"form4-04082026_050401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000012/form4-04082026_050401.xml","form_type":"4"}},{"id":812847,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-04-08T21:20:05.000Z","date":"2026-04-06","kind":"sale","planned":true,"acquired":false,"shares":1443,"price":69.75,"value":100649.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $69.30 to $70.25 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":105212,"source":{"system":"sec-edgar","filing":"0001578852-26-000012","document":"form4-04082026_050401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000012/form4-04082026_050401.xml","form_type":"4"}},{"id":812846,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-04-08T21:20:05.000Z","date":"2026-04-06","kind":"sale","planned":true,"acquired":false,"shares":822,"price":68.91,"value":56644.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $68.24 to $69.17 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":106655,"source":{"system":"sec-edgar","filing":"0001578852-26-000012","document":"form4-04082026_050401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000012/form4-04082026_050401.xml","form_type":"4"}},{"id":812845,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-04-08T21:20:05.000Z","date":"2026-04-06","kind":"exercise","planned":true,"acquired":true,"shares":2265,"price":39.42,"value":89286.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025."}],"balance_after":107477,"source":{"system":"sec-edgar","filing":"0001578852-26-000012","document":"form4-04082026_050401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000012/form4-04082026_050401.xml","form_type":"4"}},{"id":888856,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-02-23T22:20:05.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":590,"price":69.82,"value":41193.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $69.52 to $70.18 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":105212,"source":{"system":"sec-edgar","filing":"0001578852-26-000010","document":"form4-02232026_050201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000010/form4-02232026_050201.xml","form_type":"4"}},{"id":888855,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-02-23T22:20:05.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":212,"price":68.54,"value":14530.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $67.99 to $68.93 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":105802,"source":{"system":"sec-edgar","filing":"0001578852-26-000010","document":"form4-02232026_050201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000010/form4-02232026_050201.xml","form_type":"4"}},{"id":888854,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-02-23T22:20:05.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":1629,"price":69.82,"value":113736.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $69.52 to $70.18 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":106014,"source":{"system":"sec-edgar","filing":"0001578852-26-000010","document":"form4-02232026_050201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000010/form4-02232026_050201.xml","form_type":"4"}},{"id":888853,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-02-23T22:20:05.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":588,"price":68.54,"value":40301.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $67.99 to $68.93 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":107643,"source":{"system":"sec-edgar","filing":"0001578852-26-000010","document":"form4-02232026_050201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000010/form4-02232026_050201.xml","form_type":"4"}},{"id":894342,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-19T22:25:05.000Z","date":"2026-02-17","kind":"exercise","planned":true,"acquired":false,"shares":2813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Currently exercisable."}],"balance_after":22501,"derivative":{"exercise_price":25.69,"expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":2813},"source":{"system":"sec-edgar","filing":"0001578852-26-000008","document":"form4-02192026_050201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000008/form4-02192026_050201.xml","form_type":"4"}},{"id":894341,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-02-19T22:25:05.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":3081,"price":69.36,"value":213698.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,500 RSUs from a February 15, 2024 grant of 18,000 RSUs and the vesting of 1,600 RSUs from a February 15, 2024 grant of 3,200 RSUs."}],"balance_after":108231,"source":{"system":"sec-edgar","filing":"0001578852-26-000008","document":"form4-02192026_050201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000008/form4-02192026_050201.xml","form_type":"4"}},{"id":894340,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-02-19T22:25:05.000Z","date":"2026-02-17","kind":"sale","planned":true,"acquired":false,"shares":2,"price":70.13,"value":140.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."}],"balance_after":111312,"source":{"system":"sec-edgar","filing":"0001578852-26-000008","document":"form4-02192026_050201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000008/form4-02192026_050201.xml","form_type":"4"}},{"id":894339,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-02-19T22:25:05.000Z","date":"2026-02-17","kind":"sale","planned":true,"acquired":false,"shares":2811,"price":69.29,"value":194774.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $68.84 to $69.80 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":111314,"source":{"system":"sec-edgar","filing":"0001578852-26-000008","document":"form4-02192026_050201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000008/form4-02192026_050201.xml","form_type":"4"}},{"id":894338,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-02-19T22:25:05.000Z","date":"2026-02-17","kind":"exercise","planned":true,"acquired":true,"shares":2813,"price":25.69,"value":72265.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."}],"balance_after":114125,"source":{"system":"sec-edgar","filing":"0001578852-26-000008","document":"form4-02192026_050201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000008/form4-02192026_050201.xml","form_type":"4"}},{"id":941387,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-01-12T22:20:07.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":107,"price":79.52,"value":8508.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $79.35 to $79.60 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":111312,"source":{"system":"sec-edgar","filing":"0001578852-26-000006","document":"form4-01122026_050103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000006/form4-01122026_050103.xml","form_type":"4"}},{"id":941386,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-01-12T22:20:07.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":686,"price":78.71,"value":53995.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $78.23 to $79.21 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":111419,"source":{"system":"sec-edgar","filing":"0001578852-26-000006","document":"form4-01122026_050103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000006/form4-01122026_050103.xml","form_type":"4"}},{"id":941385,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-01-12T22:20:07.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":1521,"price":77.46,"value":117816.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $77.12 to $78.08 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":112105,"source":{"system":"sec-edgar","filing":"0001578852-26-000006","document":"form4-01122026_050103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000006/form4-01122026_050103.xml","form_type":"4"}},{"id":941384,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-01-12T22:20:07.000Z","date":"2026-01-08","kind":"sale","planned":true,"acquired":false,"shares":1286,"price":76.45,"value":98314.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 3,600 RSUs from a January 7, 2022 grant of 14,400 RSUs."}],"balance_after":113626,"source":{"system":"sec-edgar","filing":"0001578852-26-000006","document":"form4-01122026_050103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000006/form4-01122026_050103.xml","form_type":"4"}},{"id":941383,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-01-12T22:20:07.000Z","date":"2026-01-08","kind":"sale","planned":true,"acquired":false,"shares":265,"price":77.07,"value":20423.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $76.99 to $77.23 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":114912,"source":{"system":"sec-edgar","filing":"0001578852-26-000006","document":"form4-01122026_050103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000006/form4-01122026_050103.xml","form_type":"4"}},{"id":941382,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-01-12T22:20:07.000Z","date":"2026-01-08","kind":"sale","planned":true,"acquired":false,"shares":2482,"price":76.56,"value":190021.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.95 to $76.92 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":115177,"source":{"system":"sec-edgar","filing":"0001578852-26-000006","document":"form4-01122026_050103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000006/form4-01122026_050103.xml","form_type":"4"}},{"id":943548,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-08T22:20:08.000Z","date":"2026-01-07","kind":"exercise","planned":true,"acquired":false,"shares":751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Currently exercisable."}],"balance_after":0,"derivative":{"exercise_price":38.1,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":751},"source":{"system":"sec-edgar","filing":"0001578852-26-000004","document":"form4-01082026_050104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000004/form4-01082026_050104.xml","form_type":"4"}},{"id":943547,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-08T22:20:08.000Z","date":"2026-01-07","kind":"exercise","planned":true,"acquired":false,"shares":2625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Currently exercisable."}],"balance_after":751,"derivative":{"exercise_price":38.1,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":2627},"source":{"system":"sec-edgar","filing":"0001578852-26-000004","document":"form4-01082026_050104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000004/form4-01082026_050104.xml","form_type":"4"}},{"id":943546,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-01-08T22:20:08.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":11,"price":78.98,"value":868.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."}],"balance_after":117659,"source":{"system":"sec-edgar","filing":"0001578852-26-000004","document":"form4-01082026_050104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000004/form4-01082026_050104.xml","form_type":"4"}},{"id":943545,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-01-08T22:20:08.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":269,"price":77.92,"value":20960.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $77.54 to $78.47 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":117670,"source":{"system":"sec-edgar","filing":"0001578852-26-000004","document":"form4-01082026_050104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000004/form4-01082026_050104.xml","form_type":"4"}},{"id":943544,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-01-08T22:20:08.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":471,"price":77.1,"value":36314.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $76.54 to $77.52 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":117939,"source":{"system":"sec-edgar","filing":"0001578852-26-000004","document":"form4-01082026_050104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000004/form4-01082026_050104.xml","form_type":"4"}},{"id":943543,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-01-08T22:20:08.000Z","date":"2026-01-07","kind":"exercise","planned":true,"acquired":true,"shares":751,"price":38.1,"value":28613.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."}],"balance_after":118410,"source":{"system":"sec-edgar","filing":"0001578852-26-000004","document":"form4-01082026_050104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000004/form4-01082026_050104.xml","form_type":"4"}},{"id":943542,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-01-08T22:20:08.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":38,"price":78.6,"value":2986.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."}],"balance_after":117659,"source":{"system":"sec-edgar","filing":"0001578852-26-000004","document":"form4-01082026_050104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000004/form4-01082026_050104.xml","form_type":"4"}},{"id":943541,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-01-08T22:20:08.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":949,"price":77.91,"value":73936.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $77.58 to $78.54 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":117697,"source":{"system":"sec-edgar","filing":"0001578852-26-000004","document":"form4-01082026_050104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000004/form4-01082026_050104.xml","form_type":"4"}},{"id":943540,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-01-08T22:20:08.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":1638,"price":77.11,"value":126306.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $76.56 to $77.55 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":118646,"source":{"system":"sec-edgar","filing":"0001578852-26-000004","document":"form4-01082026_050104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000004/form4-01082026_050104.xml","form_type":"4"}},{"id":943539,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-01-08T22:20:08.000Z","date":"2026-01-07","kind":"exercise","planned":true,"acquired":true,"shares":2625,"price":38.1,"value":100012.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."}],"balance_after":120284,"source":{"system":"sec-edgar","filing":"0001578852-26-000004","document":"form4-01082026_050104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000004/form4-01082026_050104.xml","form_type":"4"}},{"id":943538,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-01-08T22:20:08.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":1503,"price":77.48,"value":116452.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,250 RSUs from a January 5, 2023 grant of 17,000 RSUs."}],"balance_after":117659,"source":{"system":"sec-edgar","filing":"0001578852-26-000004","document":"form4-01082026_050104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000004/form4-01082026_050104.xml","form_type":"4"}},{"id":943537,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-01-08T22:20:08.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":1739,"price":76.95,"value":133816.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,500 RSUs from a January 3, 2025 grant of 18,000 RSUs."}],"balance_after":119162,"source":{"system":"sec-edgar","filing":"0001578852-26-000004","document":"form4-01082026_050104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000004/form4-01082026_050104.xml","form_type":"4"}},{"id":947937,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T22:20:26.000Z","date":"2026-01-05","kind":"exercise","planned":true,"acquired":false,"shares":2266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024."}],"balance_after":9063,"derivative":{"exercise_price":39.42,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":2266},"source":{"system":"sec-edgar","filing":"0001578852-26-000002","document":"form4-01062026_050119.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000002/form4-01062026_050119.xml","form_type":"4"}},{"id":947936,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T22:20:26.000Z","date":"2026-01-02","kind":"grant","planned":true,"acquired":true,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted on January 2, 2026, and vests over four years, with 25% of the shares underlying the option vesting on January 2, 2027, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 2, 2027."}],"balance_after":42500,"derivative":{"exercise_price":76.74,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0001578852-26-000002","document":"form4-01062026_050119.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000002/form4-01062026_050119.xml","form_type":"4"}},{"id":947935,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-01-06T22:20:26.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":108,"price":76.79,"value":8293.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $76.75 to $76.81 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":120901,"source":{"system":"sec-edgar","filing":"0001578852-26-000002","document":"form4-01062026_050119.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000002/form4-01062026_050119.xml","form_type":"4"}},{"id":947934,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-01-06T22:20:26.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":1035,"price":76.1,"value":78763.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.58 to $76.42 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":121009,"source":{"system":"sec-edgar","filing":"0001578852-26-000002","document":"form4-01062026_050119.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000002/form4-01062026_050119.xml","form_type":"4"}},{"id":947933,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-01-06T22:20:26.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":1123,"price":74.92,"value":84135.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $74.55 to $75.27 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":122044,"source":{"system":"sec-edgar","filing":"0001578852-26-000002","document":"form4-01062026_050119.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000002/form4-01062026_050119.xml","form_type":"4"}},{"id":947932,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-01-06T22:20:26.000Z","date":"2026-01-05","kind":"exercise","planned":true,"acquired":true,"shares":2266,"price":39.42,"value":89325.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024."}],"balance_after":123167,"source":{"system":"sec-edgar","filing":"0001578852-26-000002","document":"form4-01062026_050119.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000002/form4-01062026_050119.xml","form_type":"4"}},{"id":947931,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2026-01-06T22:20:26.000Z","date":"2026-01-02","kind":"grant","planned":true,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted on January 2, 2026 that vest in four equal installments over four years, commencing on January 2, 2027."}],"balance_after":120901,"source":{"system":"sec-edgar","filing":"0001578852-26-000002","document":"form4-01062026_050119.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885226000002/form4-01062026_050119.xml","form_type":"4"}},{"id":994395,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-19T22:20:04.000Z","date":"2025-11-17","kind":"exercise","planned":true,"acquired":false,"shares":2812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 5, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025."}],"balance_after":25314,"derivative":{"exercise_price":25.69,"expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":2812},"source":{"system":"sec-edgar","filing":"0001578852-25-000010","document":"form4-11192025_051101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885225000010/form4-11192025_051101.xml","form_type":"4"}},{"id":994394,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2025-11-19T22:20:04.000Z","date":"2025-11-17","kind":"sale","planned":true,"acquired":false,"shares":192,"price":77.18,"value":14818.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $77.10 to $77.33 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":103901,"source":{"system":"sec-edgar","filing":"0001578852-25-000010","document":"form4-11192025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885225000010/form4-11192025_051101.xml","form_type":"4"}},{"id":994393,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2025-11-19T22:20:04.000Z","date":"2025-11-17","kind":"sale","planned":true,"acquired":false,"shares":777,"price":76.53,"value":59463.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $76.08 to $77.07 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":104093,"source":{"system":"sec-edgar","filing":"0001578852-25-000010","document":"form4-11192025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885225000010/form4-11192025_051101.xml","form_type":"4"}},{"id":994392,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2025-11-19T22:20:04.000Z","date":"2025-11-17","kind":"sale","planned":true,"acquired":false,"shares":1843,"price":75.64,"value":139404.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.06 to $76.04 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":104870,"source":{"system":"sec-edgar","filing":"0001578852-25-000010","document":"form4-11192025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885225000010/form4-11192025_051101.xml","form_type":"4"}},{"id":994391,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2025-11-19T22:20:04.000Z","date":"2025-11-17","kind":"exercise","planned":true,"acquired":true,"shares":2812,"price":25.69,"value":72240.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 5, 2024."}],"balance_after":106713,"source":{"system":"sec-edgar","filing":"0001578852-25-000010","document":"form4-11192025_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885225000010/form4-11192025_051101.xml","form_type":"4"}},{"id":1021019,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-09T21:20:05.000Z","date":"2025-10-07","kind":"exercise","planned":true,"acquired":false,"shares":3375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 5, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023."}],"balance_after":3376,"derivative":{"exercise_price":38.1,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":3375},"source":{"system":"sec-edgar","filing":"0001578852-25-000008","document":"form4-10092025_051001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885225000008/form4-10092025_051001.xml","form_type":"4"}},{"id":1021018,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2025-10-09T21:20:05.000Z","date":"2025-10-07","kind":"sale","planned":true,"acquired":false,"shares":312,"price":64.97,"value":20270.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $64.56 to $65.01 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":103901,"source":{"system":"sec-edgar","filing":"0001578852-25-000008","document":"form4-10092025_051001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885225000008/form4-10092025_051001.xml","form_type":"4"}},{"id":1021017,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2025-10-09T21:20:05.000Z","date":"2025-10-07","kind":"sale","planned":true,"acquired":false,"shares":1306,"price":63.8,"value":83322.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $63.36 to $64.25 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":104213,"source":{"system":"sec-edgar","filing":"0001578852-25-000008","document":"form4-10092025_051001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885225000008/form4-10092025_051001.xml","form_type":"4"}},{"id":1021016,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2025-10-09T21:20:05.000Z","date":"2025-10-07","kind":"sale","planned":true,"acquired":false,"shares":1757,"price":62.89,"value":110497.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $62.36 to $63.28 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":105519,"source":{"system":"sec-edgar","filing":"0001578852-25-000008","document":"form4-10092025_051001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885225000008/form4-10092025_051001.xml","form_type":"4"}},{"id":1021015,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2025-10-09T21:20:05.000Z","date":"2025-10-07","kind":"exercise","planned":true,"acquired":true,"shares":3375,"price":38.1,"value":128587.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 5, 2024."}],"balance_after":107276,"source":{"system":"sec-edgar","filing":"0001578852-25-000008","document":"form4-10092025_051001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885225000008/form4-10092025_051001.xml","form_type":"4"}},{"id":1022461,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-07T21:20:07.000Z","date":"2025-10-06","kind":"exercise","planned":true,"acquired":false,"shares":2266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 5, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024."}],"balance_after":11329,"derivative":{"exercise_price":39.42,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":2266},"source":{"system":"sec-edgar","filing":"0001578852-25-000005","document":"form4-10072025_051003.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885225000005/form4-10072025_051003.xml","form_type":"4"}},{"id":1022460,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-07T21:20:07.000Z","date":"2025-10-03","kind":"exercise","planned":true,"acquired":false,"shares":2265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 5, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024."}],"balance_after":13595,"derivative":{"exercise_price":39.42,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":2265},"source":{"system":"sec-edgar","filing":"0001578852-25-000005","document":"form4-10072025_051003.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885225000005/form4-10072025_051003.xml","form_type":"4"}},{"id":1022459,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-07T21:20:07.000Z","date":"2025-10-03","kind":"exercise","planned":true,"acquired":false,"shares":2266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 5, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024."}],"balance_after":15860,"derivative":{"exercise_price":39.42,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":2266},"source":{"system":"sec-edgar","filing":"0001578852-25-000005","document":"form4-10072025_051003.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885225000005/form4-10072025_051003.xml","form_type":"4"}},{"id":1022458,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-07T21:20:07.000Z","date":"2025-10-03","kind":"exercise","planned":true,"acquired":false,"shares":18124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 5, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024."}],"balance_after":18126,"derivative":{"exercise_price":39.42,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":18124},"source":{"system":"sec-edgar","filing":"0001578852-25-000005","document":"form4-10072025_051003.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885225000005/form4-10072025_051003.xml","form_type":"4"}},{"id":1022457,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2025-10-07T21:20:07.000Z","date":"2025-10-06","kind":"sale","planned":true,"acquired":false,"shares":2266,"price":65.07,"value":147448.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $64.72 to $65.38 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":103901,"source":{"system":"sec-edgar","filing":"0001578852-25-000005","document":"form4-10072025_051003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885225000005/form4-10072025_051003.xml","form_type":"4"}},{"id":1022456,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2025-10-07T21:20:07.000Z","date":"2025-10-06","kind":"exercise","planned":true,"acquired":true,"shares":2266,"price":39.42,"value":89325.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 5, 2024."}],"balance_after":106167,"source":{"system":"sec-edgar","filing":"0001578852-25-000005","document":"form4-10072025_051003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885225000005/form4-10072025_051003.xml","form_type":"4"}},{"id":1022455,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":21799,"kind":"person","name":"Boulding Mark Elliott","position":1,"cik":"0001578852","reported_name":"Boulding Mark Elliott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXEC. VP AND CLO"}}],"security":"Common Stock","published_at":"2025-10-07T21:20:07.000Z","date":"2025-10-03","kind":"sale","planned":true,"acquired":false,"shares":877,"price":66.67,"value":58469.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $66.42 to $67.07 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":103901,"source":{"system":"sec-edgar","filing":"0001578852-25-000005","document":"form4-10072025_051003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000157885225000005/form4-10072025_051003.xml","form_type":"4"}}],"next_cursor":"2025-10-07T21:20:07.000000Z,1022455"}